CCEL 📈 CryoCell International - Overview
Exchange: NYSE MKT • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2288951088
CCEL: Cord Blood, Stem Cells, Tissue Storage
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida. Web URL: https://www.cryo-cell.com
Additional Sources for CCEL Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CCEL Stock Overview
| Market Cap in USD | 66m |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| GiC Sub-Industry | Health Care Services |
| IPO / Inception | 1997-01-21 |
CCEL Stock Ratings
| Growth 5y | 10.1% |
| Fundamental | -9.10% |
| Dividend | 23.7% |
| Rel. Strength Industry | 676 |
| Analysts | 4/5 |
| Fair Price Momentum | 8.29 USD |
| Fair Price DCF | 5.63 USD |
CCEL Dividends
| Dividend Yield 12m | 3.19% |
| Yield on Cost 5y | 4.08% |
| Annual Growth 5y | % |
| Payout Consistency | 100.0% |
CCEL Growth Ratios
| Growth Correlation 3m | 70% |
| Growth Correlation 12m | 47% |
| Growth Correlation 5y | -20.4% |
| CAGR 5y | 5.16% |
| CAGR/Mean DD 5y | 0.14 |
| Sharpe Ratio 12m | 0.73 |
| Alpha | 28.05 |
| Beta | 0.21 |
| Volatility | 63.11% |
| Current Volume | 5.5k |
| Average Volume 20d | 12.6k |
What is the price of CCEL stocks?
As of December 22, 2024, the stock is trading at USD 7.83 with a total of 5,450 shares traded.
Over the past week, the price has changed by -0.06%, over one month by -0.51%, over three months by +18.19% and over the past year by +39.94%.
As of December 22, 2024, the stock is trading at USD 7.83 with a total of 5,450 shares traded.
Over the past week, the price has changed by -0.06%, over one month by -0.51%, over three months by +18.19% and over the past year by +39.94%.
Is CryoCell International a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, CryoCell International is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -9.10 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CCEL as of December 2024 is 8.29. This means that CCEL is currently overvalued and has a potential downside of 5.87%.
Neither. Based on ValueRay Fundamental Analyses, CryoCell International is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -9.10 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CCEL as of December 2024 is 8.29. This means that CCEL is currently overvalued and has a potential downside of 5.87%.
Is CCEL a buy, sell or hold?
CryoCell International has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy CCEL.
CryoCell International has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy CCEL.
- Strong Buy: 0
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecast for CCEL stock price target?
According to ValueRays Forecast Model, CCEL CryoCell International will be worth about 9 in December 2025. The stock is currently trading at 7.83. This means that the stock has a potential upside of +14.56%.
According to ValueRays Forecast Model, CCEL CryoCell International will be worth about 9 in December 2025. The stock is currently trading at 7.83. This means that the stock has a potential upside of +14.56%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 9 | 14.9% |
| Analysts Target Price | 10 | 27.7% |
| ValueRay Target Price | 9 | 14.6% |